Archives: Agenda

• How to ensure your study is prioritised in a competitive industry
• Aligning CRO, site and sponsor priorities so everyone is supported in working towards the same goal
• Successfully partnering a CRO team with your internal departments to allow for effective communication across all stages of the trial
• CRO monitoring and oversight: How to make processes efficient and effective

Moderator: Asiyah Nawab, Senior Healthcare Analyst (Immunology Team), GlobalData

• Data-driven Selection to Choose a Region for Your Trial Expansion
• Risk Response Strategies and a Mitigation Framework
• Clear Communication and a Culture of Accountability Among Partners
• Case Studies on Canada as a Trial Expansion Region

• Fast, Furious, or Never-Ending: Entertaining Case Studies on Accelerating and Unexpectedly Inflating Phase Ib/II Trial Timelines and Budgets. A Site Team Perspective.

Early-phase oncology development is evolving rapidly, with a growing need for smarter trial designs, faster regulatory pathways, and deeper collaboration with sites. This session explores how AI-driven protocol design, streamlined fast-track approvals, and strategic site partnerships can transform study execution from design to delivery. Through practical insights and real-world examples, we will discuss how technology and collaboration with regulators and sites can help bring therapies to patients faster.